ESE-3, a Novel Member of an Epithelium-specific Ets Transcription Factor Subfamily, Demonstrates Different Target Gene Specificity from ESE-1*

Most cancers originate as a result of aberrant gene expression in mainly glandular epithelial tissues leading to defects in epithelial cell differentiation. The latter is governed by distinct sets of transcriptional regulators. Here we report the characterization of epithelium-specific Ets factor, family member 3 (ESE-3), a novel member of the ESE subfamily of Ets transcription factors. ESE-3 shows highest homology to two other epithelium restricted Ets factors, ESE-1 and ESE-2. ESE-3, like ESE-1 and ESE-2, is exclusively expressed in a subset of epithelial cells with highest expression in glandular epithelium such as prostate, pancreas, salivary gland, and trachea. A potential role in branching morphogenesis is suggested, since ESE-3 transactivates the c-MET promoter via three high affinity binding sites. Additionally, ESE-3 binding to DNA sequences in the promoters of several glandular epithelium-specific genes suggests a role for ESE-3 in later stages of glandular epithelium differentiation. Although ESE-3 and ESE-1 bind with similar affinity to various Ets binding sites, ESE-3 and ESE-1 differ significantly in their ability to transactivate the promoters containing these sites. Our results support the notion that ESE-1, ESE-2, and ESE-3 represent a unique epithelium-specific subfamily of Ets factors that have critical but distinct functions in epithelial cell differentiation and proliferation.

[1]  T. Libermann,et al.  Characterization of ESE-2, a Novel ESE-1-related Ets Transcription Factor That Is Restricted to Glandular Epithelium and Differentiated Keratinocytes* , 1999, The Journal of Biological Chemistry.

[2]  S. Ishida,et al.  The genomic breakpoint and chimeric transcripts in the EWSR1–ETV4/E1AF gene fusion in Ewing sarcoma , 1998, Cytogenetic and Genome Research.

[3]  D. Bostwick,et al.  Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen , 1998, Cancer.

[4]  Raymond B. Runyan,et al.  Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis. , 1998, Developmental biology.

[5]  Lars S Jermiin,et al.  A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13–15, a region subject to LOH and rearrangement in human carcinoma cell lines , 1998, Oncogene.

[6]  R. Neve,et al.  The epithelium‐specific Ets transcription factor ESX is associated with mammary gland development and involution , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  David J. Anderson,et al.  Functionally Related Motor Neuron Pool and Muscle Sensory Afferent Subtypes Defined by Coordinate ETS Gene Expression , 1998, Cell.

[8]  C. Backendorf,et al.  AP-1 and Ets Transcription Factors Regulate the Expression of the Human SPRR1A Keratinocyte Terminal Differentiation Marker* , 1998, The Journal of Biological Chemistry.

[9]  P. Comoglio,et al.  HGF controls branched morphogenesis in tubular glands. , 1998, European Journal of Morphology.

[10]  Y. Liu,et al.  The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. , 1998, Gene.

[11]  B. Wasylyk,et al.  Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. , 1998, Trends in biochemical sciences.

[12]  Frank H. Burton,et al.  Molecular cloning and expression of Ehf, a new member of the ets transcription factor/oncoprotein gene family. , 1998, Biochemical and biophysical research communications.

[13]  D. Seol,et al.  Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter. , 1998, Biochimica et biophysica acta.

[14]  P. Sorensen,et al.  A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma , 1998, Nature Genetics.

[15]  Y. Bang,et al.  A Novel ets-related Transcription Factor, ERT/ESX/ESE-1, Regulates Expression of the Transforming Growth Factor-β Type II Receptor* , 1998, The Journal of Biological Chemistry.

[16]  Martin Rosenberg,et al.  A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer , 1997, Oncogene.

[17]  P. Steinert,et al.  The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. , 1997, Nucleic acids research.

[18]  P. Marynen,et al.  Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. , 1997, Blood.

[19]  T. Libermann,et al.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family , 1997, Molecular and cellular biology.

[20]  T. Golub,et al.  Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TEL , 1997, The EMBO journal.

[21]  Wen-Lin Kuo,et al.  ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis , 1997, Oncogene.

[22]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[23]  H P Koeffler,et al.  TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. , 1996, Blood.

[24]  M. Stella,et al.  Ets up-regulates MET transcription. , 1996, Oncogene.

[25]  P. van de Putte,et al.  Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation , 1996, Molecular and cellular biology.

[26]  T. Libermann,et al.  Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1 , 1996, Molecular and cellular biology.

[27]  T. Golub,et al.  Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia , 1996, Molecular and cellular biology.

[28]  W. Vainchenker,et al.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias , 1996, Molecular and cellular biology.

[29]  B. Haendler,et al.  The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. , 1996, European journal of biochemistry.

[30]  T. Taki,et al.  EWS‐FLI‐1 and EWS‐ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor , 1995, International journal of cancer.

[31]  D. Le Paslier,et al.  An integrated YAC clone contig for the WAGR region on human chromosome 11p13-p14.1. , 1995, Genomics.

[32]  F. Alt,et al.  Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene , 1995, Nature.

[33]  C. Ponting SAM: A novel motif in yeast sterile and drosophila polyhomeotic proteins , 1995, Protein science : a publication of the Protein Society.

[34]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Thummel,et al.  The Drosophila E74 gene is required for the proper stage- and tissue-specific transcription of ecdysone-regulated genes at the onset of metamorphosis. , 1995, Development.

[36]  P. Riegman,et al.  Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. , 1995, Oncogene.

[37]  A. Hart,et al.  Human ERG is a proto-oncogene with mitogenic and transforming activity. , 1995, Oncogene.

[38]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[39]  Zhou Songyang,et al.  Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.

[40]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[41]  Ernst Hafen,et al.  The ETS domain protein Pointed-P2 is a target of MAP kinase in the Sevenless signal transduction pathway , 1994, Nature.

[42]  Gerald M. Rubin,et al.  The activities of two Ets-related transcription factors required for drosophila eye development are modulated by the Ras/MAPK pathway , 1994, Cell.

[43]  T. Libermann,et al.  ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development , 1994, Molecular and cellular biology.

[44]  Todd R. Golub,et al.  Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.

[45]  H. Yamamoto,et al.  One of two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins. , 1994, Nucleic acids research.

[46]  P. Sorensen,et al.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.

[47]  K. Ozato,et al.  The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins. , 1994, Oncogene.

[48]  R. Schulz,et al.  Ets oncogene-related gene Elg functions in Drosophila oogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Libermann,et al.  Pi, a pre-B-cell-specific enhancer element in the immunoglobulin heavy-chain enhancer. , 1993, Molecular and cellular biology.

[50]  B. Erman,et al.  Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. , 1993, Science.

[51]  D. Cleveland,et al.  Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex. , 1992, Genes & development.

[52]  G. Draetta,et al.  The consensus sequences for cdc2 kinase and for casein kinase‐2 are mutually incompatible A study with peptides derived from the β‐subunit of casein kinase‐2 , 1992, FEBS letters.

[53]  M. Chrétien,et al.  Prostatic secretory protein PSP94: gene organization and promoter sequence in rhesus monkey and human. , 1991, Biochimica et biophysica acta.

[54]  A. Seth,et al.  The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. , 1990, Oncogene.

[55]  V. Arbusow,et al.  Genomic sequence of human prostate specific antigen (PSA). , 1989, Nucleic acids research.

[56]  T. Libermann,et al.  An angiogenic growth factor is expressed in human glioma cells. , 1987, The EMBO journal.

[57]  A. Bennick Structural and Genetic Aspects of Proline-rich Proteins , 1987, Journal of dental research.

[58]  B. Jakobsen,et al.  Coordination of murine parotid secretory protein and salivary amylase expression. , 1986, The EMBO journal.

[59]  D. Leprince,et al.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26 , 1983, Nature.

[60]  M. Sato,et al.  A Neoplastic Epithelial Duct Cell Line Established From An Irradiated Human Salivary Gland , 1981, Cancer.

[61]  P. van de Putte,et al.  Structure and evolution of the human SPRR3 gene: implications for function and regulation. , 1999, Genomics.

[62]  T. Pawson,et al.  The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization , 1999, Nature Structural Biology.

[63]  B. Graves,et al.  Specificity within the ets family of transcription factors. , 1998, Advances in cancer research.

[64]  O. Bernard,et al.  A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL–PDGFRβ oncoprotein , 1997, The EMBO journal.

[65]  B. Vandenbunder,et al.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. , 1992, The American journal of pathology.